DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Drug Interactions With Risk of QT-prolongation in a General Hospital

Information source: Katholieke Universiteit Leuven
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: QT-prolongation

Intervention: Haloperidol (Drug)

Phase: N/A

Status: Completed

Sponsored by: Katholieke Universiteit Leuven

Official(s) and/or principal investigator(s):
Eline Vandael, PhD-student, Principal Investigator, Affiliation: Katholieke Universiteit Leuven

Summary

In this epidemiological point prevalence study, medication profiles of patients with haloperidol treatment will be checked for drug interactions with risk of QT-prolongation. Additional clinical risk factors for developing QT-prolongation and safety measurements will be documented.

Clinical Details

Official title: Drug Interactions With Risk of QT-prolongation in a General Hospital: an Epidemiological Point Prevalence Study

Study design: Observational Model: Cohort, Time Perspective: Prospective

Primary outcome: QTc-interval (corrected for heart rate)

Secondary outcome: number of drug interactions (with risk of QT-prolongation)

Detailed description: Study design: epidemiological point prevalence study Target population: Patients with haloperidol treatment The following aspects will be investigated:

- The medication profiles will be checked for drug interactions with risk of

QT-prolongation.

- Clinical risk factors for developing QT-prolongation (gender, age, (history of)

cardiovascular disease, comorbidity,...) and lab results will be collected.

- Safety measurements (e. g. ECG) will be documented.

Eligibility

Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- treatment with haloperidol (started in the hospital)

Exclusion Criteria:

- age < 18 years

Locations and Contacts

Universitair Ziekenhuis Leuven, Leuven 3000, Belgium
Additional Information

Starting date: July 2013
Last updated: June 10, 2014

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017